Their study is a fine example of our current knowledge limitations at the time of conducting their CYP2D6 genotyping and follow up patients survey March 2008 to May 2010, most published studies, based on retrospective data, indicated that individuals having a CYP2D6 poor metabolizer genotype predictive of complete lack of the enzyme activity were less likely